Advanced Biomed, Inc. (ADVB)
4.90
-0.24
(-4.67%)
USD |
NASDAQ |
Oct 15, 13:32
Advanced Biomed Shareholders Equity (Quarterly) : 0.3854M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3854M |
| March 31, 2026 | 0.2881M |
| December 31, 2025 | 0.3018M |
| September 30, 2025 | 0.0986M |
| June 30, 2025 | 0.119M |
| March 31, 2025 | 0.1244M |
| December 31, 2024 | 0.0189M |
| September 30, 2024 | 0.0346M |
| Date | Value |
|---|---|
| December 31, 2023 | 0.0064M |
| September 30, 2023 | 0.0249M |
| June 30, 2023 | 0.0419M |
| March 31, 2023 | 0.0783M |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 0.1174M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| SBC Medical Group Holdings, Inc. | 263.84M |
| Abbott Laboratories | 51.11B |
| Acme United Corp. | 121.30M |
| Align Technology, Inc. | 4.232B |
| AngioDynamics, Inc. | 163.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.4316M |
| Total Liabilities (Quarterly) | 0.0463M |
| Debt to Equity Ratio | 0.0877 |
| Current Ratio | 9.322 |
| Net Debt Paydown Yield | -0.07% |